Shanghai Rendu (China) Performance
| 688193 Stock | 48.90 -2.45 -4.77% |
The company owns a market beta of 0.15, which implies very low measured sensitivity to broad market movements. With a sub-1 beta, Shanghai Rendu typically participates in market rallies at a reduced pace while often limiting downside exposure. Shanghai Rendu right now owns a risk of 1.84%.
Risk-Adjusted Performance
Weak
Weak | Strong |
Shanghai Rendu Biotechnology has delivered negative risk-adjusted returns across the last 90 days, suggesting that volatility was not compensated by return. Used correctly, this score supports evaluation of raw price movement versus actual return efficiency. Despite somewhat strong basic indicators, Shanghai Rendu is not utilizing all of its potential. The current price disturbance may contribute to short-term losses for investors. Learn More
Shanghai |
Relative Risk vs. Return Landscape
If you had invested Y 4,876 in Shanghai Rendu Biotechnology on December 23, 2025 and sold it today you would have earned a total of Y 14.00 from holding Shanghai Rendu Biotechnology or generated 0.29% return on investment over 90 days. Shanghai Rendu Biotechnology is generating a 0.0217% daily return and shows 1.8413% volatility on return distribution over a 90-day horizon. Simply put, 16% of stocks are less volatile than Shanghai, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Target Price Odds to finish over Current Price
The tendency of Shanghai Stock price to converge on an average value over time is a well-known pattern in finance. Despite this pattern, historical data suggests that some stocks remain persistently mispriced until markets correct. Persistent mispricings are often associated with additional risk factors that the market prices gradually over time.
| Current Price | Horizon | Target Price | Odds moving above the current price in 90 days |
| 48.90 | 90 days | 48.90 | about 75.03 |
Based on a normal probability distribution, the odds of Shanghai Rendu moving above the current price in 90 days from now are about 75.03 . The calculation reflects the observed volatility and distributional characteristics of this stock. This statistical estimate provides a baseline expectation, not a guarantee of future outcomes. (This Shanghai Rendu Biotechnology probability density function shows the probability of Shanghai Stock falling within a particular price range over 90 days). Wider distributions indicate higher uncertainty about where Shanghai Stock will trade after 90 days. Compare this distribution across different time horizons to understand how uncertainty scales for Shanghai Stock.
Shanghai Rendu Price Density |
| Price |
Predictive Modules for Shanghai Rendu
Numerous approaches exist for forecasting the stock market and estimating future values of Shanghai Rendu. Although accurate forecasting remains elusive, the process of modeling scenarios is a valuable part of decision-making. The most effective strategy is often to combine methods and recognize that uncertainty limits any single forecast.Experienced market participants anticipate that Shanghai Rendu's price will even out over time. Periods when Shanghai Rendu's deviates significantly from its historical mean may warrant further fundamental analysis. Experienced Shanghai Rendu's investors use mean reversion as a complement to momentum analysis.
Primary Risk Indicators
The last 10-20 years have been a volatile period for the stock market, and Shanghai Rendu is no exception. Shanghai Rendu has experienced periods of rapid price declines followed by equally strong recoveries. A hedging strategy that accounts for Shanghai Rendu's changing volatility and elasticity can protect against downside risk.α | Alpha over Dow Jones | 0.08 | |
β | Beta against Dow Jones | 0.15 | |
σ | Overall volatility | 2.68 | |
Ir | Information ratio | 0.08 |
Investor Alerts and Insights
Automated alerts tied to Shanghai Rendu help investors stay ahead of material changes in stock conditions. Shanghai Rendu notifications flag important changes in technical indicators, fundamentals, and market conditions. The notification system covers both scheduled events and unexpected stock movements for Shanghai Rendu.| The company reported revenue of 177.35 M. Net Loss for the year was -7.81 M with profit before overhead, payroll, taxes, and interest of 125.87 M. | |
| About 58.0% of the company shares are owned by insiders or employees |
Shanghai Rendu Fundamentals Growth
Shanghai Stock prices reflect investors' perceptions of Shanghai Rendu's future prospects and financial health. Revenue trajectory, earnings quality, profit margins, and leverage levels shape Shanghai Stock market performance. Shanghai Rendu's revenue trajectory, earnings quality, and leverage are the key drivers of Shanghai Stock market valuation.
| Return On Equity | -0.0059 | |||
| Return On Asset | -0.0194 | |||
| Profit Margin | -0.03 % | |||
| Operating Margin | 0.17 % | |||
| Current Valuation | 1.22 B | |||
| Shares Outstanding | 40.07 M | |||
| Price To Book | 2.18 X | |||
| Price To Sales | 12.43 X | |||
| Revenue | 177.35 M | |||
| EBITDA | -15.83 M | |||
| Total Debt | 82.48 M | |||
| Book Value Per Share | 23.68 X | |||
| Cash Flow From Operations | 24.39 M | |||
| Earnings Per Share | -0.14 X | |||
| Total Asset | 994.36 M | |||
| Retained Earnings | 115.83 M | |||
Performance Metrics & Calculation Methodology
Shanghai Rendu performance is measured on a risk-adjusted basis against benchmarks. Cycle participation patterns help identify regime alignment. Certain defensive traits may reduce sensitivity to broader macroeconomic fluctuations. Shanghai Rendu shows ROE of -0.59%, ROA of -1.94%.
For Shanghai Rendu Biotechnology, this section uses periodic company reporting and market reference feeds with Macroaxis normalization rules applied to keep cross-asset comparisons consistent. Intraday timing differences may exist. Return and risk statistics are calculated from historical price series.